Cancer Drug Mark-Ups: The Worst Proven Price Increases
Cancer drug mark-ups have soared to 700%, raising concerns over affordability and access.
Rare disease drug approval: A second chance worth taking
Rare disease drug approval is back in the spotlight as a once-spurned treatment gets a second chance at regulatory approval.